Biotech · Private company · San Carlos, CA, US

Onc.Ai, Inc.

Track this companyFree. Adds Onc.Ai, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.Fiscal year 2026 · $313.7KNIH RePORTER 5R44CA302212-02 · fetched Nov 12, 2026
Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.Fiscal year 2025 · $1.7MNIH RePORTER 1R44CA302212-01 · fetched Nov 12, 2026
Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapyFiscal year 2025 · $375KNIH RePORTER 5R44CA291456-02 · fetched Nov 12, 2026
Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapyFiscal year 2024 · $1.6MNIH RePORTER 1R44CA291456-01A1 · fetched Nov 12, 2026